Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

97.45
Delayed Data
As of 4:02pm ET
 +1.15 / +1.19%
Today’s Change
59.27
Today|||52-Week Range
98.87
+55.62%
Year-to-Date
Pfizer's Arthritis Drug Gets FDA Nod for Label Expansion
3:12pm / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Sickle Cell Disease Drug
Dec 12 / Zacks.com - Paid Partner Content
6 Stocks Beating the Market
2:49pm / GuruFocus News - Paid Partner Content
AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan
Dec 06 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo/Yervoy sBLA for RCC Accepted by FDA
2:16pm / Zacks.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data
Dec 06 / Zacks.com - Paid Partner Content
Pfizer's Second Biosimilar of Remicade Receives FDA Approval
Dec 14 / Zacks.com - Paid Partner Content
AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study
Dec 05 / Zacks.com - Paid Partner Content
Roche/AbbVie Report Positive Phase III Results on Venclexta
Dec 13 / Zacks.com - Paid Partner Content
Lilly's (LLY) Taltz Gets Approval for Label Expansion in US
Dec 04 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Reports Positive Data on Leukemia Drug
Dec 12 / Zacks.com - Paid Partner Content
3 Drug/Biotech Stocks in Focus on World AIDS Day
Dec 01 / Zacks.com - Paid Partner Content